These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 23933235)

  • 21. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs.
    Hashimoto Y; Shimizu T; Mima Y; Abu Lila AS; Ishida T; Kiwada H
    Toxicol Appl Pharmacol; 2014 May; 277(1):30-8. PubMed ID: 24632081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
    Kozma GT; Mészáros T; Vashegyi I; Fülöp T; Örfi E; Dézsi L; Rosivall L; Bavli Y; Urbanics R; Mollnes TE; Barenholz Y; Szebeni J
    ACS Nano; 2019 Aug; 13(8):9315-9324. PubMed ID: 31348638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity.
    Mima Y; Abu Lila AS; Shimizu T; Ukawa M; Ando H; Kurata Y; Ishida T
    J Control Release; 2017 Mar; 250():20-26. PubMed ID: 28179196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
    Wang X; Ishida T; Kiwada H
    J Control Release; 2007 Jun; 119(2):236-44. PubMed ID: 17399838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ["PEG dilemma" for liposomes and its solving approaches].
    Zhang D; Xu H; Hu MN; Deng YH
    Yao Xue Xue Bao; 2015 Mar; 50(3):252-60. PubMed ID: 26118102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.
    Elsadek NE; Emam SE; Abu Lila AS; Shimizu T; Ando H; Ishima Y; Ishida T
    Biol Pharm Bull; 2020; 43(9):1393-1397. PubMed ID: 32879214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
    Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
    Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan.
    Li C; Zhao X; Wang Y; Yang H; Li H; Li H; Tian W; Yang J; Cui J
    Int J Pharm; 2013 Feb; 443(1-2):17-25. PubMed ID: 23318366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.
    Abu-Dief AM; Alsehli M; Awaad A
    Histochem Cell Biol; 2022 Jun; 157(6):641-656. PubMed ID: 35157114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles.
    Zhao Y; Wang L; Yan M; Ma Y; Zang G; She Z; Deng Y
    Int J Nanomedicine; 2012; 7():2891-900. PubMed ID: 22745552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
    Xu H; Ye F; Hu M; Yin P; Zhang W; Li Y; Yu X; Deng Y
    Drug Deliv; 2015; 22(5):598-607. PubMed ID: 24524364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEGylated nanoemulsions containing 1,2-distearoyl-sn-glycero-3-phosphoglycerol induced weakened accelerated blood clearance phenomenon.
    Li Z; Gao X; Yan X; Deng Y; Ma H
    Drug Deliv Transl Res; 2022 Oct; 12(10):2569-2579. PubMed ID: 35094294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.
    Shiraishi K; Hamano M; Ma H; Kawano K; Maitani Y; Aoshi T; Ishii KJ; Yokoyama M
    J Control Release; 2013 Feb; 165(3):183-90. PubMed ID: 23220106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy.
    Yang Q; Ma Y; Zhao Y; She Z; Wang L; Li J; Wang C; Deng Y
    Int J Nanomedicine; 2013; 8():1257-68. PubMed ID: 23576868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-PEG IgM Production via a PEGylated Nanocarrier System for Nucleic Acid Delivery.
    Abu Lila AS; Ishida T
    Methods Mol Biol; 2019; 1943():333-346. PubMed ID: 30838627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights.
    Liu M; Chu Y; Liu H; Su Y; Zhang Q; Jiao J; Liu M; Ding J; Liu M; Hu Y; Dai Y; Zhang R; Liu X; Deng Y; Song Y
    Mol Pharm; 2020 Apr; 17(4):1059-1070. PubMed ID: 31860321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zwitterionic stealth peptide-protected gold nanoparticles enable long circulation without the accelerated blood clearance phenomenon.
    Zhao J; Qin Z; Wu J; Li L; Jin Q; Ji J
    Biomater Sci; 2017 Dec; 6(1):200-206. PubMed ID: 29199748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles.
    Koide H; Asai T; Kato H; Ando H; Shiraishi K; Yokoyama M; Oku N
    Int J Pharm; 2012 Aug; 432(1-2):75-9. PubMed ID: 22562054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.
    Elsadek NE; Lila ASA; Emam SE; Shimizu T; Takata H; Ando H; Ishima Y; Ishida T
    Eur J Pharm Biopharm; 2020 Jul; 152():56-62. PubMed ID: 32376372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.